Skip to main
MYO

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc. has demonstrated strong growth in its reimbursement pipeline, with the number of units rising to 1,669 in the latest quarter compared to 1,611 in the previous quarter, reflecting increasing demand for its myoelectric orthotics. The company is strategically redirecting its focus towards the expanding Medicare market, which is expected to contribute significantly to its revenue, with O&P providers anticipated to comprise approximately 22% of revenue in 2024. Furthermore, a recent favorable ruling from the Centers for Medicare & Medicaid Services has substantially broadened the potential market for the MyoPro device, creating a positive outlook for the company's future financial performance.

Bears say

Myomo Inc. has revised its 2025 revenue guidance downwards, now anticipating $40 to $42 million, a significant decrease from the previous estimate of $50 to $53 million. Additionally, the company's marketing and pipeline performance has been subpar, adversely impacting lead quality and conversion rates, signaling potential challenges in customer acquisition. Furthermore, the authorized insurance backlog has declined consistently, dropping to 208 from 230 in the previous quarter, indicating a weakening demand that may further hinder revenue growth.

Myomo (MYO) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Jan 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.